Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
NIH's precision medicine program 'All of Us' to launch in May — 5 things to know
on April 18, 2018 at 3:50 pm
The National Institutes of Health's precision medicine program, dubbed "All of Us," is slated to launch in May, agency director Francis Collins, MD, PhD, said during a Capitol Hill testimony in early April, as reported by the Politico Morning eHealth ... […]
Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives
on April 18, 2018 at 6:14 am
New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening ANN ARBOR, Mich., April 18, 2018 /PRNewswire/ -- Swift Biosciences today announced the commercial ... […]
Precision Medicine Market size, Comprehensive Market Study with focus on Company Profile, Product and Service, Business Operation Data, Market Share
on April 18, 2018 at 5:38 am
Precision Medicine market maintains the average annual growth rate of XXXX million $ in 2013 to XXXX million $ in 2017, The Data scientists predict that in the upcoming few years Precision Medicine market will be expanded to the next level. This Research ... […]
RTI International invests in genomics, precision medicine startup – Here’s why
on April 17, 2018 at 12:30 pm
RESEARCH TRIANGLE PARK – RTI International is branching out its efforts to fulfill the nonprofit’s global mission of improving the human condition by investing in an emerging genomics and precision medicine startup. RTI invested an undisclosed amount ... […]
Personalized Medicine accepted for coverage by MEDLINE
on April 17, 2018 at 9:36 am
The journal draws research manuscripts from clinical researchers, laboratory researchers, ethicists and lawyers to put a spotlight on some of the key areas in the growing field of personalized and precision medicine. Senior Editor Geoffrey Ginsburg ... […]
Precision medicine offers solution to treat different medical problems
on April 17, 2018 at 5:57 am
Hypertension can be hard to treat. Different patients respond differently to medications. A treatment that works for one patient may not work for everyone. Large drug trials cannot explain how each individual will respond to treatment. Large trials do not ... […]
Top Cancer Centers Adopt Tapestri by Mission Bio for Precision Genomics Research
on April 16, 2018 at 5:01 am
development and delivery of precision medicine. The Tapestri platform leverages proprietary droplet microfluidics to provide unmatched single-cell DNA analysis and throughput, enabling detection of genomic variability within and across cell populations. […]
Why Cardiology Is the Next Frontier for Precision Medicine
on April 13, 2018 at 5:06 pm
When President Obama announced the Precision Medicine Initiative at the State of the Union in 2015, it recognized more than a decade of work that scientists and medical researchers had already committed to identify the underlying genetic causes of diseases ... […]
Delivering on the Value Proposition of Precision Medicine: The View From Healthcare Payers
on April 13, 2018 at 9:27 am
Jane Null Kogan, PhD; Philip Empey, PharmD, PhD; Justin Kanter, MA; Donna J. Keyser, PhD, MBA; and William H. Shrank, MD, MSHS Genomics-based precision medicine has the potential to transform healthcare delivery. However, effective collaborations among ... […]
Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers
on April 13, 2018 at 3:03 am
Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press. […]
via Google News and Bing News